Hot Pursuit     27-Jun-22
Alembic Pharmaceuticals Ltd gains for third straight session
Alembic Pharmaceuticals Ltd is quoting at Rs 746.15, up 2.69% on the day as on 12:49 IST on the NSE. The stock is down 25.51% in last one year as compared to a 0.41% spurt in NIFTY and a 13.77% spurt in the Nifty Metal index.

Alembic Pharmaceuticals Ltd is up for a third straight session in a row. The stock is quoting at Rs 746.15, up 2.69% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is up around 1.15% on the day, quoting at 15879.75. The Sensex is at 53333.72, up 1.15%. Alembic Pharmaceuticals Ltd has risen around 1.3% in last one month.

Meanwhile, Nifty Metal index of which Alembic Pharmaceuticals Ltd is a constituent, has risen around 3.05% in last one month and is currently quoting at 12178.4, up 0.88% on the day. The volume in the stock stood at 71350 shares today, compared to the daily average of 85305 shares in last one month.

The benchmark June futures contract for the stock is quoting at Rs 748.05, up 2.85% on the day. Alembic Pharmaceuticals Ltd is down 25.51% in last one year as compared to a 0.41% spurt in NIFTY and a 13.77% spurt in the Nifty Metal index.

The PE of the stock is 17.98 based on TTM earnings ending March 22.

Previous News
  Alembic Pharma Q4 PAT zooms to Rs 153 cr; R&D spend at Rs 136 crore
 ( Hot Pursuit - 06-May-23   14:44 )
  Board of Alembic Pharmaceuticals recommends final dividend
 ( Corporate News - 06-May-23   09:20 )
  Alembic Pharma reports turnaround Q1 numbers
 ( Hot Pursuit - 05-Aug-23   12:56 )
  Alembic Pharmaceuticals' derma unit at Karakhadi clears USFDA inspection
 ( Corporate News - 13-Mar-23   09:08 )
  Alembic Pharmaceuticals to discuss results
 ( Corporate News - 17-Oct-23   10:13 )
  Board of Alembic Pharmaceuticals recommends final dividend
 ( Corporate News - 09-May-24   14:56 )
  Alembic Pharmaceuticals to table results
 ( Corporate News - 22-Jul-23   11:01 )
  Board of Alembic Pharmaceuticals recommends Final Dividend
 ( Corporate News - 05-May-23   17:26 )
  Alembic Pharmaceuticals to table results
 ( Corporate News - 01-Nov-22   12:10 )
  Alembic Pharma gets USFDA nod for Desonide cream
 ( Hot Pursuit - 09-Dec-22   11:01 )
  Alembic receives USFDA approval for Diclofenac Sodium Topical Solution
 ( Corporate News - 01-Dec-22   11:17 )
Other Stories
  Metal stocks edge lower
  08-Jul-24   14:01
  Basic materials shares fall
  08-Jul-24   14:01
  Consumer Durables stocks slide
  08-Jul-24   14:00
  Central Bank of India eases for fifth straight session
  08-Jul-24   13:36
  Apollo Tyres Ltd eases for fifth straight session
  08-Jul-24   13:35
  Reliance Industries Ltd up for third straight session
  08-Jul-24   13:06
  Oil & Natural Gas Corpn Ltd rises for third consecutive session
  08-Jul-24   13:05
  Zydus Lifesciences Ltd spurts 0.43%, up for five straight sessions
  08-Jul-24   13:01
  Dr Reddys Laboratories Ltd gains for fifth session
  08-Jul-24   13:01
  HPL Electric soars after inking MoU with China-based Guangxi Ramway Tech
  08-Jul-24   12:40
Back Top